Price
No data yet.
Social Signal Score
Revenue
$0.00-100.00%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Eric Weisblum
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 3
- Beta
- 0.80
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -4.82
Financials
Revenue
$0.00-100.0%Net Income
$-832.8K-113.0%EBITDA
$-988.8KFree Cash Flow
$-781.9KEPS (diluted)
$-0.76-101.6%Shares Outstanding (diluted)
1.10M+726.4%Operating Expenses
$928.9KCash & Debt
$5.43MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $72.1K | $-4.23M | $-7.50 |
| 2024 | $72.1K | $-4.39M | $-17.85 |
| 2023 | $72.1K | $-3.70M | $-18.00 |
| 2022 | $72.1K | $-3.91M | $-25.65 |
| 2021 | $71.3K | $3.90M | $19.80 |
| 2020 | $0.00 | $-3.04M | $-35.25 |
| 2019 | $40.6K | $-1.01M | $-18.60 |
| 2018 | $0.00 | $-969.5K | $-14.85 |
| 2017 | $847.4K | $356.5K | $7.50 |
| 2016 | $-669.5K | $-1.11M | $-16.65 |
| 2015 | $-145.2K | $-409.5K | $-6.00 |
| 2014 | $-107.1K | $-376.5K | $-5.85 |
| 2013 | $105.5K | $32.9K | $0.76 |
| 2012 | $0.00 | $-39.4K | $-0.97 |
Valuation
SILOhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsglobenewswire.com·21h ago·Neutral
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment Follows recent European patent grant and coverage in multiple international markets as Silo continues to strengthen licensed IP portfolio for lead therapeutic program
View source ↗
Earnings
Wed, Dec 2(in 3 months)
Consensus estimate $-4.80 per share
Typical surprise -121.3% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$-0.76 vs $-0.32miss
- Wed, May 13$-1.80 vs $-0.32miss
- Thu, Nov 13$-0.12 vs $-0.20beat
- Wed, Aug 13$-0.19 vs $-0.20beat
- Fri, May 9$-3.45 vs $-0.21miss
- Fri, Mar 28$-0.41 vs $-0.20miss
Estimates and results for SILO via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by SILO officers and directors.
- Bought
- $71k
- Sold
- —
44 trades
0 trades
- Weisblum Ericbought
- Weisblum Ericbought
- Weisblum Ericbought
- Weisblum Ericbought
- Weisblum Ericbought
- Weisblum Ericbought
- Weisblum Ericbought
- Weisblum Ericbought
36 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.